InsidersTradesSigma
Browse the full record of transactions filed by Wadlinger Mary E., Dirigeant. Director active across 1 companies, notably Forma Therapeutics Holdings, Inc.. Cumulatively, 1 disclosures have been logged. Total volume traded: €40k. The latest transaction was disclosed on 23 February 2022 (Cession). Regulator: SEC (Form 4). All data is openly available.
1 of 1 declaration
Mary E. Wadlinger is an Executive at Forma Therapeutics Holdings, Inc. She plays a role in the management and strategy of the company, contributing to its development and growth. Her expertise is important for Forma Therapeutics' success.